| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |